07:00 , Jun 1, 2015 |  BC Week In Review  |  Financial News

i-Optics completes venture financing

i-Optics Corp., The Hague, the Netherlands   Business: Diagnostic   Date completed: 2015-05-22   Type: Venture financing   Raised: EUR13.7 million ($15.6 million)   Investors: Aescap Venture Management; HBM Partners; De Hoge Dennen; NIBC; HealthCrest Group; IPF Partners; company management...
07:00 , Mar 30, 2015 |  BioCentury  |  Finance

Poland backing innovators

The Polish government is backing the country's first life sciences VC to help build innovative life science companies in a country known for its services-oriented healthcare sector. While the capital and infrastructure are available, one...
08:00 , Jan 19, 2015 |  BC Week In Review  |  Financial News

Orphazyme completes venture financing

Orphazyme ApS, Copenhagen, Denmark   Business: Endocrine/Metabolic   Date completed: 2015-01-09   Type: Venture financing   Raised: EUR20 million ($23.6 million)   Investors: Kurma Partners; Idinvest Partners; Novo A/S; Sunstone; Aescap Venture Management   ...
07:00 , Oct 28, 2013 |  BC Week In Review  |  Financial News

F-star Alpha completes venture financing

F-star Alpha Ltd., Cambridge, U.K.   Business: Cancer   Date completed: 10/23/13   Type: Venture financing   Raised: €9.4 million ($12.9 million)   Investors: Atlas Ventures; Aescap Venture Management; TVM Capital; SR One; MP Healthcare Venture Management; MS Ventures   ...
07:00 , May 20, 2013 |  BioCentury  |  Finance

Merck Serono's earnest money

Four years after launching a strategic venture fund, the Merck Serono S.A. unit of Merck KGaA is making a long-term commitment with an infusion of €60 million ($77.8 million). While the fund's focus will remain on...
07:00 , Sep 12, 2011 |  BC Week In Review  |  Financial News

Orphazyme completes venture financing

Orphazyme ApS, Copenhagen, Denmark   Business: Endocrine/Metabolic   Date completed: 9/8/11   Type: Venture financing   Raised: €14 million ($19.8 million)   Investors: Aescap Venture Management; Novo A/S; Sunstone   ...
08:00 , Feb 7, 2011 |  BC Week In Review  |  Financial News

to-BBB completes venture financing

to-BBB technologies B.V., Leiden, the Netherlands   Business: Drug delivery, Cancer, Neurology   Date completed: 2/3/11   Type: Venture financing   Raised: €4 million ($5.4 million)   Investors: Industrial Bank of Taiwan; Jonghoud International; Aescap Venture Management; Antea Participaties   ...
07:00 , Apr 12, 2010 |  BC Week In Review  |  Financial News

Biocartis completes venture financing

Biocartis S.A., Lausanne, Switzerland   Business: Diagnostic   Date completed: 4/8/10   Type: Venture financing   Raised: €30 million ($40.5 million)   Investors: Debiopharm Group; Johnson & Johnson Development Corp.; Aescap Venture Management; Biovest CVA; Advent Venture Partners; company...
07:00 , Mar 29, 2010 |  BC Week In Review  |  Financial News

Aquapharm completes venture financing

Aquapharm Biodiscovery Ltd., Oban, U.K.   Business: Infectious   Date completed: 3/23/10   Type: Venture financing   Raised: £4.2 million ($6.3 million)   Investors: Aescap Venture Management; Tate & Lyle Ventures; Highlands and Islands Enterprise; Nesta   ...
07:00 , Jun 30, 2008 |  BioCentury  |  Product Development

Betting on modified vs. natural

Morquio syndrome only affects about 3,000 people in the developed world but Vivendy Therapeutics Ltd. and BioMarin Pharmaceutical Inc. believe there’s enough opportunity to compete for the market. Vivendy’s investors agree, as the company last...